.png)
Moberg Pharma
Moberg Pharma: A setback for the US study (Redeye)
2024-09-13 08:55
Redeye comments on the lowered expectations of the primary endpoint in the ongoing phase 3 trial.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se